![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
Laboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal
The role of ATP on the modulation of noradrenaline release elicited by electrical stimulation (100 pulses/8 Hz) was studied in the prostatic portion of rat vas deferens preincubated with [3H]noradrenaline. In the presence of P1 antagonists, the nucleotides 2-methylthioadenosine-5'-triphosphate (2-MeSATP), 2-methylthioadenosine 5'-diphosphate (2-MeSADP), ADP, and ATP decreased electrically evoked tritium overflow up to 44%, with the following order of potency: 2-MeSATP > 2-MeSADP > ADP
ATP. The P2Y antagonists reactive blue 2 (RB2) and 2-methylthioadenosine 5'-monophosphate (2-MeSAMP) increased, whereas the P2X antagonist pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) decreased evoked tritium overflow. The inhibitory effect of 2-MeSATP was antagonized by RB2 (10 µM) and by 2-MeSAMP (10 µM) but not by the selective P2Y1 receptor antagonist 2'-deoxy-N6-methyladenosine 3',5'-bisphosphate (MRS 2179; 10 µM). When, besides P1 receptors, inhibitory P2Y receptors were blocked with RB2,
,
-methyleneadenosine 5'-triphosphate (
,
-meATP),
,
-imidoadenosine 5'-triphosphate (
,
-imidoATP),
,
-methyleneadenosine 5'-triphosphate (
,
-meATP), 2-MeSATP, and ATP enhanced tritium overflow up to 140%, with the following order of potency:
,
-meATP > 2-MeSATP = ATP =
,
-meATP
,
-imidoATP. The facilitatory effects of
,
-MeATP and
,
-imidoATP were prevented by PPNDS. Under the same conditions, apyrase attenuated, whereas the ectonucleotidase inhibitor 6-N,N-diethyl-D-
,
-dibromomethylene 5'-triphosphate enhanced tritium overflow, an effect that was prevented by PPNDS. In the prostatic portion of the rat vas deferens, endogenous ATP exerts a dual and opposite modulation of noradrenaline release: an inhibition through activation of P2Y receptors with a pharmacological profile similar to that of the P2Y12 and P2Y13 receptors and a facilitation through activation of P2X receptors with a pharmacological profile similar to that of P2X1 and P2X3, or PX2/P2X3 receptors.
Address correspondence to: Dr. Jorge Gonçalves, Laboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Rua Aníbal Cunha, 164, 4050-047 Porto, Portugal. E-mail: jorge.goncalves{at}ff.up.pt
This article has been cited by other articles:
![]() |
U. Schaefer, T. Machida, M. J. Broekman, A. J. Marcus, and R. Levi Targeted Deletion of Ectonucleoside Triphosphate Diphosphohydrolase 1/CD39 Leads to Desensitization of Pre- and Postsynaptic Purinergic P2 Receptors J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1269 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ghildyal, D. Palani, and R. Manchanda Post- and prejunctional consequences of ecto-ATPase inhibition: electrical and contractile studies in guinea-pig vas deferens J. Physiol., September 1, 2006; 575(2): 469 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Rodrigues, T. Almeida, P. J. Richardson, C. R. Oliveira, and R. A. Cunha Dual Presynaptic Control by ATP of Glutamate Release via Facilitatory P2X1, P2X2/3, and P2X3 and Inhibitory P2Y1, P2Y2, and/or P2Y4 Receptors in the Rat Hippocampus J. Neurosci., July 6, 2005; 25(27): 6286 - 6295. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Machida, P. M. Heerdt, A. C. Reid, U. Schafer, R. B. Silver, M. J. Broekman, A. J. Marcus, and R. Levi Ectonucleoside Triphosphate Diphosphohydrolase1/CD39, Localized in Neurons of Human and Porcine Heart, Modulates ATP-Induced Norepinephrine Exocytosis J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 570 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Papp, T. Balazsa, A. Kofalvi, F. Erdelyi, G. Szabo, E. S. Vizi, and B. Sperlagh P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 973 - 980. [Abstract] [Full Text] [PDF] |
||||